Cargando…
Absorption, metabolism, and excretion of [ (14)C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers
Dersimelagon (formerly MT‐7117) is a novel, orally administered nonpeptide small molecule selective agonist for melanocortin 1 receptor currently being investigated for the treatment of erythropoietic protoporphyria, X‐linked protoporphyria, and diffuse cutaneous systemic sclerosis (dcSSc). Findings...
Autores principales: | Tsuda, Minoru, Ogawa, Kei, Endou, Tadashi, Goto, Takahiro, Ogasawara, Yuko, Ogasawara, Akihito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116397/ https://www.ncbi.nlm.nih.gov/pubmed/37078227 http://dx.doi.org/10.1002/prp2.1084 |
Ejemplares similares
-
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist
por: Ogasawara, Akihito, et al.
Publicado: (2023) -
Melanogenic effect of dersimelagon (MT‐7117), a novel oral melanocortin 1 receptor agonist
por: Suzuki, T., et al.
Publicado: (2021) -
Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis
por: Kondo, Masahiro, et al.
Publicado: (2022) -
Absorption, metabolism and excretion of opicapone in human healthy volunteers
por: Loureiro, Ana I., et al.
Publicado: (2022) -
The Importance of Melanocortin Receptors and Their Agonists in Pulmonary Disease
por: Moscowitz, Anna Elizabeth, et al.
Publicado: (2019)